Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial (Q37179956)
Jump to navigation
Jump to search
scientific article published on 31 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial |
scientific article published on 31 January 2013 |
Statements
1 reference
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial (English)
1 reference
Kaj Blennow
1 reference
Frederik Barkhof
1 reference
Peter Bartenstein
1 reference
Axel Rominger
1 reference
Julius Popp
1 reference
Katharina Buerger
1 reference
Yaroslav Winter
1 reference
Frank Jessen
1 reference
Richard Dodel
1 reference
Martin Farlow
1 reference
Markus Otto
1 reference
Stefan Förster
1 reference
Jan-Philipp Bach
1 reference
Judith Alferink
1 reference
Jens Wiltfang
1 reference
Piero Antuono
1 reference
Michael Jacoby
1 reference
Ralph Richter
1 reference
James Stevens
1 reference
Isaac Melamed
1 reference
Jerome Goldstein
1 reference
Stefan Haag
1 reference
Stefan Wietek
1 reference
31 January 2013
1 reference
1 reference
233-243
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference